ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer

Chen, Binshen; Zhang, Yiming; Li, Chaoming; Xu, Peng; Gao, Yubo; Xu, Yawen*南方医科大学
Archives of Medical Science2021DOI: 10.5114/aoms.2020.92939
16被引7阅读
引用收藏
分享

摘要

Introduction: Therapy options for prostate cancer (PCa) typically are centered on docetaxel-based chemotherapy but are limited by the effects of multi-drug resistance. Recent advances have illustrated a role of contactin-1 (CNTN-1) in tumor chemoresistance, while the function and mechanism of CNTN-1 in the resistance of docetaxel in prostate cancer have not yet been elucidated. @@@ Material and methods: Docetaxel (Dox)-resistant PCa cell lines of PC3 (PC3-DR) and DU145 (DU145-DR) were established, and short hairpin RNA (shR-NA) constructs targeting CNTN-1 were generated to analyze the effect of knockdown of CNTN-1 on PCa progression. Cell Counting Kit-8 (CCK-8), flow cytometry, wound-healing, transwell and western blotting analysis were used to analyze cell proliferation, apoptosis, migration, invasion and related protein expression levels, respectively. @@@ Results: Knockdown of CNTN-1 in PC3-DR and DU145-DR cells attenuated cell proliferation, migration, invasion, EMT phenotype, and drug resistance, and increased cell apoptosis further reduced the tumorigenic phenotype. Knockdown of CNTN-1 resulted in an anti-tumor effect in the xenograft tumor model, and decreased activity of the phosphoinositide 3-kinase (PI3K/Akt signaling pathway both in vitro and in vivo. @@@ Conclusions: The results of the present study suggest that downregulation of CNTN-1 may be an important mechanism to reverse chemoresistance in Dox-resistant PCa progression, thus shedding light on the development of novel anti-tumor therapeutics for the treatment of PCa.

学科与关键词

关键词
contactin-1epithelial-mesenchymal transitiondocetaxelchemoresistancePI3K/Aktprostate cancer
相关
加载中…
  • The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
    Cheng, Bisheng; Li, Lingfeng; Wu, Yongxin; Luo, Tianlong; Tang, Chen; Wang, Qiong; Zhou, Qianghua; Wu, Jilin; Lai, Yiming; Zhu, Dingjun*; Du, Tao; Huang, Hai*Cell and Bioscience, 2023, 13(1): 211.被引 1
  • Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response
    Yan Judy; Tang Damu*Experimental Cell Research, 2014, 328(1): 132-142.
  • LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway
    Chen, Binshen; Xu, Kai; Zhang, Yiming; Xu, Peng; Li, Chaoming; Liu, Jun; Xu, Yawen*Cancers, 2023, 15(6): 1902.
查看全部 →

发表信息

论文状态
公开发表
期刊
Archives of Medical Science
发表日期
2021
卷期
第 17 卷, 第 1 期
页码
152-165
DOI
10.5114/aoms.2020.92939
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • C

    Chen, Binshen (第一作者)

    southern med univ

  • Z

    Zhang, Yiming

    southern med univ

查看全部 6 位作者收起作者
  • L

    Li, Chaoming

    southern med univ

  • X

    Xu, Peng

    southern med univ

  • G

    Gao, Yubo

    southern med univ

  • X

    Xu, Yawen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417